Germany vs Russian Federation: Deaths from Parkinson's disease
Germany
12,778 deaths
in 2021
Russian Federation
10,108 deaths
in 2021
Germany rank
5th
Russian Federation rank
6th
Deaths from Parkinson's disease over time
- Germany
- Russian Federation
How they compare
Germany currently reports 12,778 deaths against 10,108 deaths in Russian Federation, a difference of 2,670 deaths.
That makes Germany's figure about 1.3 times Russian Federation's.
The two have swapped places 3 times across 22 shared years of data; in 2000 it was Russian Federation ahead.
Germany ranks 5th and Russian Federation ranks 6th of 194 countries.
Across the 3 decades both report, Germany averaged higher in 1 and Russian Federation in 2.
Head to head by decade
| Decade | Germany | Russian Federation | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5,431 deaths | 8,003 deaths | 2,572 deaths | Russian Federation |
| 2010s | 9,823 deaths | 10,016 deaths | 193.07 deaths | Russian Federation |
| 2020s | 12,805 deaths | 9,853 deaths | 2,952 deaths | Germany |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher deaths from parkinson's disease, Germany or Russian Federation?
- Germany, at 12,778 deaths against 10,108 deaths in Russian Federation as of 2021.
- What is the difference in deaths from parkinson's disease between Germany and Russian Federation?
- 2,670 deaths, with Germany ahead.
- How many years of comparable data are there for Germany and Russian Federation?
- 22 years are reported by both, from 2000 to 2021.
- How do Germany and Russian Federation rank globally for deaths from parkinson's disease?
- Germany ranks 5th and Russian Federation ranks 6th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Deaths from Parkinson's disease. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from parkinson disease in both sexes.